Rachel F. Bogdanoff
Papers
2
Total Citations
20
H-Index
2
About
Rachel F. Bogdanoff is a biomedical researcher whose work focuses on the pulmonary health impacts of electronic cigarettes, with a particular emphasis on how flavoring agents and vaping topography influence respiratory toxicity. Her major contributions center on the development and application of the HUMITIPAA, a biomimetic robotic system that simulates human vaping to provide real-time analysis of inhaled aerosolized particles. This innovative tool allows for precise, reproducible measurements of how changes in e-liquid chemistry—such as the addition of menthol flavoring—alter particle generation and deposition. Her most cited study (2023, 17 citations) demonstrated that menthol-flavored e-liquids are associated with increased micro- and sub-micron particle inhalation and worsened lung function in combustion cigarette smokers, directly linking a popular flavoring to measurable physiological harm. Bogdanoff’s work is notable for bridging engineering and clinical toxicology, providing a controlled, mechanistic framework to evaluate the real-time pulmonary risks of emerging vaping products. Her findings are critical for informing public health policy and regulatory decisions regarding flavor bans and device safety standards.
Research Focus
Key Achievements
Top Papers
- 1
- 2